Atlas Trials

Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis

Clinical trial NCT04692766 · COMPLETED

Trial details

NCT number
NCT04692766
Sponsor
R-Pharm International, LLC
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Pericarditis
Start date
2020-02-12
Primary completion
2022-01-24
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.